PFE · News · 20260922N

Strategic Initiatives

PFIZER INC · 2026-09-22 · Importance 68 · Surprise 58

Pfizer is shifting its growth strategy away from COVID-19 products toward new and acquired medicines, vaccines, and oncology products. Acquired and launched products accounted for 21.2% of revenue and grew 18% year over year, exceeding the materiality threshold for a year-over-year metric. The company is also prioritizing oncology, vaccines, and obesity treatments while using AI to improve commercial productivity.

Key facts